Navigation Links
BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors
Date:12/9/2009

different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: that the U.S. government and ex-U.S. governments may choose not to issue additional orders for peramivir and such orders, if any, may not be profitable for BioCryst; that to the extent peramivir is used as a treatment for H1N1 flu (or other strains of flu), there can be no assurance that it will prove effective; that HHS may further condition, reduce or eliminate future funding of the peramivir program; that ongoing peramivir clinical trials or our peramivir program in general may not be successful; that BioCryst or its licensees may not commence as expected additional human clinical trials with our product candidates; that our product candidates may not receive required regulatory clearances from the FDA; that ongoing and future pre-clinical and clinical development may not have positive results; that we or our licensees may not be able to continue future development of our current and future development programs; that our development programs and partnerships may never result in future product, license or royalty payments being received by BioCryst; that BioCryst may not be able to retain its current pharmaceutical and biotechnology partners for further development of its product candidates or it may not reach favorable agreements with potential pharmaceutical and biotechnology partners for further development of its product candidates; that our actual cash burn rate may not be consistent with our expectations; that BioCryst may not have sufficient cash to continue funding the development, manufacturing, marketing
'/>"/>
SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
2. BioCryst Provides Forodesine HCl Update
3. BioCryst Updates Peramivir Clinical Development Plan
4. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
5. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
6. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
7. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
8. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
9. BioCryst Provides Update Regarding Peramivir for Influenza
10. BioCryst Clarifies Government Declaration Regarding Peramivir
11. BioCryst to Present at JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 Simplified Genetics , the only provider ... and safety in the U.S., announced today the launch of ... improved overall health found within specific genes – all with ... The tests include Simply Fit and ... genetic analysis that maps four key genes to provide individuals ...
(Date:9/2/2015)... 2, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... and Chief Executive Officer, will present a corporate ... Conference, sponsored by H.C. Wainwright & ... 2015 at the St. Regis Hotel in New ...
(Date:9/2/2015)... SAINT PAUL, Minn. , Sept. 2, 2015 /PRNewswire/ ... company, today scheduled a conference call to discuss its ... ended July 31, 2015. The call will be at ... Company will report financial results for the third quarter ... September 10, 2015. Participants can dial ...
Breaking Medicine Technology:Simplified Genetics Decodes DNA's Blueprint for Individual Health and Safety 2Simplified Genetics Decodes DNA's Blueprint for Individual Health and Safety 3RegeneRx to Present at Rodman & Renshaw Global Investment Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 3MGC Diagnostics Corporation to Report Third Quarter Fiscal 2015 Financial Results on Thursday, September 10, 2015 2
(Date:9/2/2015)... ... September 02, 2015 , ... A third party administrator (TPA) ... seeing a significant increase in unlawful tactics used by out-of-network (OON) ambulatory surgical ... of OON ASCs encouraging members to have elective procedures done at their facilities ...
(Date:9/2/2015)... ... 2015 , ... Amada Senior Care, premier provider of in-home care and assisted ... County location. Amada franchise partners Mike and Mell Fleming came to the senior ... over 20 years in medical device sales while Mell spent over 30 years as ...
(Date:9/2/2015)... ... September 02, 2015 , ... EDAC Systems, Inc., ... management solutions and services to both government and commercial clients, today announced the ... utility for IBM’s Datacap document capture platform. EDAC PurePAGE processes and enhances ...
(Date:9/2/2015)... ... 2015 , ... “ G-Hold ” was featured on NewsWatch as part of ... consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review ... a tablet while reducing the likelihood of it dropping. , Tablets like the iPad ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Pentec Health, Inc., ... Inc. 5000 List for an impressive sixth consecutive year. Less than 5 % of ... twelve firms in the “health” sector. Pentec’s 3-year revenue growth rate of 65% ...
Breaking Medicine News(10 mins):Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2Health News:Pentec Health Once Again Named One of the Fastest-Growing Private Companies in America 2
... a Phase 1 clinical trial on a new experimental ... first new class of anti-TB drugs in the past ... and drug-resistant TB. The study is the first ... the National Institutes of Health through the Hinckley-based research ...
... protecting bikers, brains, may also be contributing to hearing ... find out why. The distinctive roar of a ... biggest source of noise for motorcyclists is actually generated ... legal speeds, the sound can exceed safe levels. Now, ...
... have received a major funding boost of 550,000 from ... into the pathological processes underpinning Alzheimer,s disease, the most ... the UK. The funding will be used to ... electrical signalling go wrong in the Alzheimer,s disease brain. ...
... (HealthDay News) -- Low blood pressure while undergoing dialysis ... blood vessels are connected to the dialysis machine, a ... a sudden drop in blood pressure during dialysis can ... and long-term problems such as stroke, seizure, heart damage ...
... research focusing on high-frequency oscillations, termed ripples and ... provide an important marker for the localization of ... to the study now available in Epilepsia ... Epilepsy (ILAE), the resection of brain regions containing ...
... Crawford, PhD, a clinical associate professor of psychiatry and ... at Boston University School of Medicine (BUSM), has been ... Excellence in Diversity Training by the Association of Psychology ... presented to Crawford during the American Psychological Association,s Convention ...
Cached Medicine News:Health News:Scientists receive funding boost to further research into disease mechanisms of Alzheimer’s 2Health News:Blood Pressure Drop During Dialysis May Raise Clot Risk 2Health News:Fast ripples confirmed to be valuable biomarker of area responsible for seizure activity in children 2
... protein 4 (IGFBP-4) is a 24 kDa protein ... IGF-I and IGF-II. It is also present in ... 28 kDa. IGFBP-4 has been identified in all ... types, including fibroblasts, neuroblastoma, prostate and bone cells ...
... the adrenal gland and gonads, is the ... both of which may be subsequently converted ... activity, estimated at ~(less than or equal ... androstenedione levels often exceed testosterone in both ...
... Inhibins are heterodimeric proteins that suppress ... from the pituitary. Inhibin consists of two ... linked together. Inhibin A consists of the ... the alpha-subunit and betaB-subunit. Only the dimeric ...
... a 7.5 kDa peptide which is secreted primarily ... mitogenic and metabolic actions involved in cellular growth. ... to target cell receptors. IGF-II binds with high ... monomeric protein which also serves as the receptor ...
Medicine Products: